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The COVID- 19 pandemic caused severe ventilator shortages in many healthcare systems 
worldwide. The UK government reacted to this with a three- pronged approach of import-
ing, up- scaling existing production and supporting new design projects. The latter two parts 
– labelled the UK Ventilator Challenge – included over 50 companies from various sectors 
including the automotive and aerospace industries. Nine multi- partner consortia and five 
single- company projects were initiated with varying approaches. This study explores lessons 
learned during the setup and management of these medical device designs and manufac-
turing consortia. A qualitative survey methodology was employed, and 32 semi- structured 
stakeholder interviews were conducted. The primary data was triangulated through the col-
lection of 42 secondary data sources such as webinars and radio interviews. Transcription 
and a three- step data analysis process of thematic coding identified six lessons learned. The 
analysis of the data showed that a strong, appealing common goal can enable employee 
motivation and trust as well as align priorities across all companies involved. This facilitates 
the involvement and fruitful collaboration of companies with varying sizes and fields of 
expertise. Furthermore, selecting the most suitable employees with specialist knowledge for 
high- priority projects and empowering them to make decisions can have a positive effect on 
project performance. The findings from the study complement existing literature on new 
product development and crisis management processes. In addition, the results uncover 
potential long- term effects such as more openness for cross- sector collaborations, which can 
serve as interesting sources for further research.
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1.  Introduction
The outbreak and worldwide spread of the coro-navirus SARS- CoV- 2 and the resulting disease 
COVID- 19 has caused global health- related shocks 
(WHO, 2020a). A study by Yang et al. (2020) sug-
gests that approximately 76% of COVID- 19- patients 
are asymptomatic or have only mild symptoms, while 
the remaining 24% develop severe and critical symp-
toms. These patients require different respiratory 
treatments, ranging from non- invasive options such 
as Continuous Positive Airway Pressure (CPAP) to 
sedation and intubation for mechanical ventilation 
(Yang et al., 2020).
In early March 2020, due to rapidly rising numbers 
of COVID- 19 cases, the UK National Health Service 
(NHS) projected an urgent need for up to 30,000 ven-
tilators, with just over 8,000 then actually available 
(Balogun, 2020; National Audit Office, 2020). In 
response, the UK government implemented a three- 
pronged strategy: (i) importing ready- made devices 
from overseas, (ii) scaling- up existing domestic pro-
duction, and (iii) supporting the rapid development 
and manufacturing of new device designs. Since 
global ventilator supplies were very limited due to 
the pandemic, increasing imports proved ineffective 
and the latter two prongs – jointly labelled the ‘UK 
Ventilator Challenge’ (UKVC1) – were given prior-
ity. Essentially, the government’s approach was to 
maximise speed and chance of success before con-
sidering costs (National Audit Office, 2020). This 
initiative brought together over 50 companies across 
diverse sectors ranging from medical devices (MD) 
to the automotive, aerospace and defense industries. 
From this community, five single company projects 
and nine multi- partner consortia projects were initi-
ated as shown in Figure 1.
The EU regulations define MDs as: “any instru-
ment, apparatus, appliance, software, implant, 
reagent, material or other article intended by the 
manufacturer to be used, alone or in combination, 
for human beings” (EU Parliament, 2017, p. 117/15). 
Ventilators fall into the second- highest regulatory 
classification (Class IIb) and are subject to multiple 
regulatory assessments such as CE- marking, clinical 
trials and an assessment of the technical documen-
tation (EU Parliament, 2017). Notified Bodies are 
independent certification bodies designated by the 
National Competent Authority i.e. the Medicines and 
Healthcare products Regulatory Agency (MHRA) in 
the UK. While the MHRA is responsible for setting 
and enforcing the MD standards, testing and certi-
fication are handled by one of the three Notified 
Bodies in the UK. MD manufacturers also require 
certification of the ISO13485 quality management 
system (QMS). These requirements make medical 
device development (MDD) a complex and lengthy 
process associated with many uncertainties and high 
costs (Marešová et al., 2020).
The projects pursued different strategies regard-
ing design and clinical sophistication. Some 
used existing or adapted designs, whilst others 
developed new devices ranging from emergency 
ventilators using resuscitation bags to more sophis-
ticated ventilator designs exceeding the Rapidly 
Manufactured Ventilator System (RMVS) spec-
ification,2 as shown in Figure  2. Striped projects 
successfully ran through the approval stages and 
collectively produced over 15,000 ventilators 
(National Audit Office, 2020). Out of the 11 new 
and adapted designs, four devices “achieved a 
performance level which met the [UK regulatory 
body] requirements” (Cabinet Office, 2020a). The 
remaining projects either did not meet the required 
Figure 1. Overview of UKVC projects and involved companies (Brand logos from company websites).
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specification or were stopped due to lower than ini-
tially anticipated demand (Cabinet Office, 2020b). 
Early modelling (1st March 2020) of the reason-
able worst- case scenario by NHS England and 
Improvement suggested the potential need for up 
to 90,000 mechanical ventilator beds at the fore-
casted peak of 13th April 2020. With the positive 
impact of mitigations such as social distancing, the 
anticipated urgent demand did not materialise and 
the forecast was lowered to 17,500 on 24th March 
2020 (National Audit Office, 2020).
Successfully running through the design, devel-
opment, regulatory and clinical trial stages in the 
MDD normally takes several years. While much 
research is concerned with MDD acceleration tech-
niques under ‘normal’ conditions, collaboratively 
developing and manufacturing a complex, safety- 
critical Class IIb MD in response to a global pub-
lic health emergency within extremely short time 
frames is less well addressed in the literature. To 
address this gap, a general research question (RQ) 
was formulated:
What can be learned from analysing the experiences 
of the rapid setup and management of medical device 
design and manufacturing consortia in response to 
the COVID- 19 crisis?
The remainder of this paper is structured as fol-
lows. We review the literature to position this topic 
within existing research areas, outline the subsequent 
research gap and formulate a more precise research 
question. We then explain the choice of methodol-
ogy and present the research design including data 
collection and analysis methods. Next, the findings 
of the primary and secondary data are presented 
and discussed by linking them back to the literature. 
Finally, we draw the key conclusions, reflect on the 
limitations of this study and present possible areas 
for future research.
2.  Literature review
This topic is positioned within three areas of knowl-
edge: New Product Development (NPD) for MDs 
(MDD), crisis- response consortia within the broader 
literature on multi- partner collaborations, and the 
setup and management of NPD projects in the con-
text of crises.
2.1.  New product development and medical 
device development
Most of the UKVC companies demonstrated expe-
rience and advanced capabilities in NPD, but the 
regulatory and clinical requirements of MDs make 
development processes particularly challenging for 
organisations with little or no prior experience in 
the sector. Therefore, we explored prior work on the 
special characteristics and requirements of MDs and 
associated development processes.
Building on the developments in the literature 
around NPD, including the stage- gate system by 
Cooper (1990), various researchers have reviewed 
MDD processes and formulated multi- phase mod-
els (Pietzsch et al., 2009; Medina et al., 2013; 
Ocampo and Kaminski, 2019). Since regulatory 
requirements and pathways vary significantly for 
different MDs and regulatory bodies, there is no 
consistent understanding of the number of phases 
and their content. However, Marešová et al. (2020) 
Figure 2. Design approaches & clinical sophistication levels of UKVC projects (excl. Gemini due to lack of information).
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discovered that most studies identify five overar-
ching steps: (1) Need assessment & Initiation; (2) 
Conceptualisation; (3) Design, Development & 
Production Planning; (4) Verification & Validation 
and (5) Production & Post- Launch. Hence, MDD 
involves a complex, multi- phase process (Marešová 
et al., 2020).
Since the MD industry is one of the most R&D inten-
sive sectors with investments of around 7% of annual 
revenue (EvaluateMedTech, 2018), MD companies 
constantly search for critical success factors (CSFs) 
that facilitate a shorter time- to- market without losing 
quality and compliance. Table  1 summarises CSFs 
uncovered by several researchers that studied MDD 
processes in SMEs and large companies.
2.2.  Multi- partner collaboration
Research identifies multi- partner arrangements as a 
key element of strategies to successfully manage cer-
tain types of public policy challenges (Bryson et al., 
2015). In their recent study, Crick and Crick (2020) 
conclude that such collaboration models among rivals 
can lead to performance- enhancing business models 
in response to crises such as COVID- 19. The com-
plex regulatory requirements of MDD require both 
successful cross- functional teamwork within compa-
nies (Holland et al., 2000) and the close involvement 
of different partners such as regulatory bodies.
Figure  3 summarises the different organisa-
tions/groups and their connections within the 
UKVC. The light grey box represents the UKVC 
project teams that were concerned with the MDD 
task, whereas the dark grey box includes the sup-
ply chain and assembly capabilities that were 
also required to build the ventilators. Outside the 
UKVC manufacturing ecosystem, the projects had 
to manage communication with government and 
regulatory bodies. To enable effective communi-
cation and inter- project coordination, the UK gov-
ernment appointed an intermediary organisation 
(PA Consulting). Due to the various stakeholders 
involved and since “cross- sector collaboration is 
hardly an easy answer to complex public prob-
lems” (Bryson et al., 2015, p. 648), the influencing 
dimensions and success factors of multi- partner 
Table 1. CSFs identified in the MDD literature
Area of application Authors Study type Critical success factors
Stage- gate process for 
MDD
Pietzsch et al. 
(2009)
>80 expert interviews • Knowledge about regulatory 
requirements
• Experience and skills of the engineers 
involved
Product design process 
model for MDD
Medina et al. 
(2013)
Expert interviews for 
model validation
• Effective execution of MDD process
• User involvement in design reviews 
and verification
Evaluation of MDD suc-
cess factors




• Availability of experts and their 
experience
• Active involvement of stakeholders in 
all MDD stages
• Complete elicitation of end- user 
requirements
• Make clinicians “the partners in 
progress”
• Level of integration of different func-
tional departments of the organisation
• Sound performance measurement 
system
Supply chain manage-




Case study with 15 
interviews
• Training and commitment of staff
• Cooperation and knowledge exchange 
between OEM and supply chain
• Appropriate information systems to 
support decision making in SCM
• Efficient tracking and tracing of medi-
cal technology in the SC for quality 
and compliance
• Reduction of complexity in the 
design of products and manufacturing 
processes
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collaborations in the literature are reviewed in the 
following section.
To address the complexity of collaborations 
of organisations from different sectors, Bryson 
et al. (2006) formulated a theoretical framework 
describing conditions, structure and constraints. 
Following that, many scholars developed concepts 
emphasising different aspects of cross- sector col-
laborations. For example, Provan and Kenis (2007) 
focused on how modes of collaboration governance 
can address legitimacy to avoid evolving tensions 
between participants. Other studies focused on 
communication practices (Koschmann et al., 2012) 
and leadership structures and processes (Agranoff, 
2012). In 2015, Bryson et al. analysed the develop-
ment of the research area and synthesised multiple 
theoretical and empirical studies in a joint frame-
work (Figure 4).
Bryson et al. address the antecedent conditions 
that lead to the formation of collaborations such 
as the UKVC, where the MD sector was unable to 
meet the unexpected, enormous ventilator demand. 
Even with favourable antecedent conditions, the 
formation of collaborations still depends on specific 
Figure 3. Stakeholder map of UKVC with different collaboration paths.
Figure 4. Synthesis of theoretical frameworks on cross- sector collaborations (Adapted from Bryson et al., 2015).
© 2021 The Authors. R&D Management published by RADMA and John Wiley & Sons Ltd.
Carl- Magnus von Behr, Georgia Anne Semple and Tim Minshall
6 R&D Management 2021
initial conditions such as pre- existing relationships 
which have a significant impact on collaboration 
structures. Furthermore, endemic conflicts such as 
multiple institutional logics need to be managed 
effectively for productive collaborations (Bryson et 
al., 2006).
In addition to the public value of synergising 
multiple sectors’ capabilities, the outcome of cross- 
sector collaborations categorise into first- , second- 
and third- order effects. First- order effects are direct 
collaboration results such as new intellectual capi-
tal, while second- order effects occur outside project 
boundaries, e.g. joint learning. Lastly, third- order 
effects only become apparent in the long- term such 
as decreased destructive conflict (Innes and Booher, 
1999).
2.3.  Crisis management in NPD projects
With its rapid global spread, the World Health 
Organisation (WHO) declared COVID- 19 as a 
“public health emergency of international concern” 
(PHEIC) on 30th January 2020 (WHO, 2020b). 
According to the WHO, an emergency is “a state 
in which normal procedures are suspended and 
extraordinary measures are taken to avert a disas-
ter” (WHO, 2002, p. 10). In comparison, a disaster 
is defined as “an occurrence disrupting the normal 
conditions of existence and causing a level of suf-
fering that exceeds the capacity of adjustment of the 
affected community” (WHO, 2002, p. 3). The terms 
emergency, disaster and crisis are “closely intercon-
nected, interdependent and overlap significantly” 
(Al- Dahash et al., 2016, p. 1191), in that an emer-
gency can turn into a disaster, while a disaster is 
inherently an emergency.
The shortage of ventilators during the COVID- 19 
pandemic can be portrayed as a crisis situation. 
Pedersen et al. (2020, p. 315) define “a crisis as a 
sequence of events that can have substantial nega-
tive consequences if not managed appropriately”. 
For NPD, crises are caused by undesired and unex-
pected events and are connected with high time and 
result pressure (Lindemann, 2009). They can exist 
on technical, social, or organisational levels and 
affect the ability to reach important milestones in 
the development process. Such crises can be caused 
by worker shortage, uncertainty of information or 
stress and anxiety related to the threatening nature 
of the crisis (Muenzberg et al., 2016). While many 
crises have an economic aspect, the COVID- 19 cri-
sis impacted organisations differently, as investi-
gated by Cortez and Johnston (2020) who identified 
the main differences between prior financial- based 
crises such as the 2008– 2009 subprime crisis and 
the COVID- 19 crisis: The COVID- 19 crisis is char-
acterised by (i) a focus on the individual humans 
rather than the business and (ii) a highly disrupted 
everyday life for whole populations with signif-
icant government interventions such as quaran-
tines and temporarily closed businesses (Cortez 
and Johnston, 2020). Combined with the need 
for remote working and virtual communication, 
the unknown time span of COVID- 19 pandemic 
impacted business operations severely.
Despite major events such as 9/11 or the 2008– 
2009 subprime crisis, there is a surprising lack of 
research focusing on crisis management (Pedersen 
et al., 2020). Regarding crisis management in NPD 
projects, Akgün et al. (2006) investigated 319 NPD 
teams and concluded that a perceived crisis is pos-
itively linked to new knowledge creation. In a later 
study, Akgün et al. (2007) found that a high degree 
of management support facilitates speed- to- market 
and new product success. A recent study by Samra 
et al. (2019) suggests that a high level of perceived 
crisis can result in better new product performance. 
Muenzberg et al. (2016) provided the first detailed 
study of NPD crises by analysing 15 industrial 
NPD projects, in which participants reported cri-
ses of diverse natures. Within these, the environ-
ment and causes of the crisis, the crisis itself and 
the effects of the crisis were investigated. Eight 
common context factors were identified as shown 
in Table 2.
2.4.  Key issues arising from the literature 
review
The literature on MDD predominantly deals with 
effectively managing the information inputs from 
multi- disciplinary stakeholders. To shorten time- 
to- market, various studies have researched CSFs in 
the MDD process. The literature on multi- partner 
collaborations is well developed with varying 
forms and characteristics. Factors such as institu-
tional logics and trust among collaborators are con-
sidered crucial for collaboration success. Lastly, 
NPD crisis management is a nascent literature area 
that deals with the adaptation of project manage-
ment to successfully solve crises. Factors such as 
the level of perceived crisis and the degree of man-
agement support have been identified to influence 
NPD performance.
2.5.  Research gap
Drawing upon the concepts identified in the literature 
review and contextual data relating to COVID- 19 in 
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the UK, Figure  5 summarises the issues and their 
interconnectivity relating to the UKVC projects. 
The COVID- 19 pandemic affected the two inner lev-
els with various challenges such as uncertainty and 
result pressure. In the middle layer, the setup and 
management of consortia is divided into the phases 
of project formation, operation and outcome. During 
the project operation phase, the projects faced the 
MDD process, which is separated into technical 
competency, project enablers as well as project and 
knowledge management. In this process, the efforts 
and capabilities of the involved organisational groups 
needed to be effectively aligned. The project outcome 
phase encompasses the short- term to long- term out-
comes (e.g. addressing short- term ventilator shortage 
through to regulatory framework changes to support 
future crisis responses).
Prior research on developing and building Class 
IIb MDs in extremely short timeframes using non- 
specialist capabilities and under the constraints of a 
global pandemic is very limited. Some parallels with 
UKVC can be observed from analysis of the polio 
Table 2. Context factors and CSFs for NPD crises (Muenzberg et al., 2016)
Context factors Critical success factors
Project risk
• Caused by high result & time pressure and unclear information 
situation
Corporate level
• Good corporate culture
• Securing sufficient capacities
• Support with decisions making by top 
management
Project level
• Clear, short, quick, and timely 
communication
• Managers should give clear targets
• Experienced and authentic team leader
• Experienced team members




• Ability to work under pressure
• Trust on all levels
Personnel level
• Network: colleagues, external partners
• Reliable network
• Communication with the right persons
• Start early communication
• Communication with the customer
• Early integration of all relevant partners
Priority & Management support
• Caused by far- reaching consequences and high result & time pressure
Degree of motivation/ morale, Project motive, Motivation
• Caused by far- reaching consequences, high project priority for dam-
age prevention, and management attention
Reward and recognition
• Caused by high project risk, high project priority, high internal & 
external recognition and high reward for crisis solvers ‘fire fighters’
High pressure to succeed
• Caused by far- reaching consequences and ‘must not’ fail project
Individual time pressure
• Caused by high result, time pressure, and higher workload & longer 
working hours
Coordination and division of work
• Caused by high project priority, high risk, decoupling from ‘daily 
business’ and need of special competences
Type of project control
• Caused by management attention & support, high motivation, and 
direct report to and control by management control
Figure 5. Conceptual framework for analysing the UKVC.
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pandemic that infected, paralysed and killed thou-
sands of children around the world. When the epi-
demic hit Australia in the 1930s, the so- called ‘Iron 
Lung’ – a negative pressure ventilator developed by 
Drinker et al. in the late 1920s – was deemed too 
heavy, bulky, and expensive. As a result, Edward 
and Donald Both rapidly developed a simplified 
Iron Lung made of plywood at a fraction of the cost 
(Markel, 1994). In following polio outbreaks around 
the world, further advancements in mechanical 
ventilation were achieved by individual engineers 
(Slutsky, 2015; Wertheim, 2020). As such, a research 
gap could be identified in that, so far, little research 
has been conducted to investigate lessons learned 
in disaster response manufacturing consortia. The 
detailed research question is therefore:
What lessons can be synthesised from the rapid setup 
and management of the medical device design and 
manufacturing consortia to support future rapid de-
sign and scale- up projects?
3.  Research method
3.1.  Research strategy & design
To explore the experiences of the different UKVC 
stakeholders, various research methods outlined by 
Yin (2009) were considered. Since this study focuses 
on contemporary events and the researcher has no 
control over the events, the survey method was cho-
sen to obtain a comprehensive picture of the expe-
riences and facilitate differential comparisons in 
settings and approaches.
3.2.  Data collection
At the outset, stakeholders on project manage-
ment and team member levels such as designers 
and engineers were targeted with the aim of higher 
responsiveness and availability as compared to top 
management stakeholders. However, due to a high 
level of media interest, many stakeholders had signed 
non- disclosure agreements, which meant that some 
individuals on operational levels within UKVC 
organisations were hesitant to contribute to this 
research. In contrast, most top management stake-
holders showed a high level of interest in the research 
project, were willing to share their experiences, and 
were able to comment on operational project aspects.
To triangulate the perspectives of the multi- 
partner consortia, stakeholders in the wider collab-
oration network (as shown in Figure  3), including 
regulatory and policy experts, suppliers delivering 
to multiple consortia and stakeholders from non- 
government supported projects with other respiratory 
solutions such as negative- pressure ventilators were 
interviewed. In total, 32 interviews with stakehold-
ers from 30 different organisations were conducted. 
Table  3 illustrates the sources of both primary and 
secondary data. Personal information was anony-
mised, and interviewee codes used that linked the 
individual to a specific project and role.
In addition to the primary data collection, an 
extensive secondary data collection was conducted. 
Due to the large public interest in the different proj-
ects, many stakeholders were questioned to reflect on 
experiences in radio interviews, podcasts or webinars. 
Lastly, many companies published case studies elab-
orating on lessons learned. In this way, over 50 sec-
ondary data sources from companies involved were 
recorded and filtered for relevance to the RQ, result-
ing in 42 selected sources of secondary data. Both pri-
mary and secondary data collection was completed in 
the time span from May to August 2020.
3.3.  Data analysis
Primary and secondary qualitative data was anal-
ysed following the “Gioia method” using the cod-
ing software Nvivo (Gioia et al., 2013). In this 
three- step process, the first step involved iden-
tifying themes in the raw data and summarising 
them in coding nodes. The first iteration of coding 
reduced the data to quotes, sentences or paragraphs 
that proved relevant to the RQ. The data was clus-
tered into different coding types. Data that pro-
vided information about the projects was labelled 
as contextual. Furthermore, lessons learned from 
overcoming encountered challenges were iden-
tified and differentiated between specific to the 
UKVC- situation and applicable to future design 
and development projects. Subsequently, the cre-
ated nodes were analysed for overarching topics 
and regrouped accordingly. Then, the second itera-
tion of coding was performed to identify previously 
overlooked passages. Lastly, the codes were organ-
ised following overarching categories, each con-
taining multiple codes with lessons learned. These 
were then analysed by comparing interviewee 
quotes and triangulating them with the secondary 
data. The results were then interpreted in the con-
text of existing literature.
4.  Findings and discussion
In this section, we present and discuss the results of 
the data analysis focusing on the project operation 
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phase of the conceptual framework (Figure  5). 
Lessons learned from the four identified categories 
are illustrated with interview quotes (in italics) and 
discussed by linking them to the existing literature.
4.1.  Project enablers
The challenges of convening organisations from 
diverse sectors with different ways of operating to 
work collaboratively emerged clearly from the data, 
and this is a well- reported topic in the literature 
(e.g. Holland et al., 2000). However, interviewees 
described how the national imperative overrode many 
of the more normal commercial, selfish behaviours, 
resulting in altruistic behaviours which interviewees 
described as “no Not- Invented- Here”, “no- blame 
culture” and “egoless behaviours”. The importance 
of such factors for effective collective group- thinking 
has been demonstrated in prior research (e.g. Holland 
et al., 2000), but it is acknowledged that the applica-
tion in business “may seem like an unattainable goal 
to those with extensive experience of the pathologies 
of group life” (Hamilton and Zammit, 2008, p. 44).
Another important factor is trust, described by 
Bryson et al. (2015, p. 653) as the “essence of col-
laboration”. Since the different UKVC projects 
involved collaborations of partners with and without 
pre- existing relationships, projects started with vary-
ing degrees of trust. Many respondents identified the 
nationwide, common goal to deliver ventilators as one 
of the key collaboration drivers. The importance of 
this “single, easily understood, […] very compelling 
objective” was noted widely in the data. Interviewees 
stated how this helped enable a culture that reduced 
commercial competitive tensions and encouraged 
accessing and applying the best resources available. 
This phenomenon is often referred to as “collective 
goals” (Bryson et al., 2015, p. 649). Nevertheless, it 
was also noted by interviewees that such a trust- based 
culture was not established immediately and building 
that trust was something that required support. The 
team at VCUK described the process of “norming, 
storming, performing” referring to the model estab-
lished by the psychologist Bruce Tuckman (1965) 
describing the transformation process of groups to 
high- performance teams.
The UKVC illustrates issues common to the setup 
of any collaborative NPD project. However, this 
case also highlights the amplifying effect of having 
a compelling, easily understandable, easily commu-
nicable message on the development of trust between 
partners and willingness to actively suppress poten-
tially negative behaviours.
4.2.  Technical competency
MDD processes generally start with the elicitation of 
clinical requirements and end- user needs (Pietzsch 
et al., 2009; Kirkire and Rane, 2017). Due to the 
novel nature of COVID- 19, clinical understanding 
evolved during the UKVC. The UK Department of 
Health created an initial RMVS which was described 
by one interviewee as “a mishmash of all of the ISO 
standards for ventilators”. The MHRA had what 
Table 3. Overview of the data collection
Perspective Function Scale- up New & adapted 
design
Primary data (Total=32) Inside project Design/IT 1 2
Human Factors 1 2
Manufacturing & Assembly 4 1
Supply Chain Management 1 1
Top Management 6 4
Total inside project interviews 13 10
Outside project Supplier 1 3
Experts (Regulatory & Policy) 2
Other respiratory solutions 3
Total outside project interviews 9
Type Scale- up New & adapted 
design
Secondary data (Total = 42) Secondary interview 7 1
Video 5 3
Podcast/Online Q&A 7 1
Case Study/Webinar 9 9
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was described as an “unenviable position, balancing 
risk- benefit and an emergency situation with much 
less time than normal to review applications”. As 
the understanding of the clinical requirements of 
COVID- 19 patients evolved, the RMVS specifica-
tion was updated three times within three weeks as 
shown in Figure 6.
To react to the changing requirements, the applica-
tion of specialist knowledge – not only MD- specific 
– was necessary. For the UKVC, some organisations 
from non- MD sectors found that their own operat-
ing environment had parallels with those of MDs 
and hence some barriers were lower than for other 
organisations. For example, aerospace companies 
were already used to operating a highly regulated, 
safety- focused environment. Motorsport companies 
have some of the quickest turnaround times between 
design and prototype which made them well suited 
for the rapid prototyping of ventilator components 
(Anderson, 2020). As argued by Preikschas et al. 
(2014), fighting against a crisis by combining the 
resources of different firms in industrial relationships 
can enable goals to be achieved that could not be 
achieved alone. Hence, these companies were able to 
leverage their expertise in a new project environment.
Nevertheless, the involvement of the original 
equipment manufacturer (OEM) ventilator compa-
nies (e.g. Smiths Medical and Penlon) in the scal-
ing- up process was critical to help the consortia 
navigate the complex regulatory paths at the heart 
of MD design and manufacture. However, these spe-
cialist ventilator firms had limited bandwidth to sup-
port others as they were focused on scaling up their 
own production. Hence, involving additional MD 
manufacturers such as Siemens Healthineers and 
Inspiration Healthcare helped to support non- MD 
consortia members, for example, with ensuring com-
pliance with MD certification. Kirkire and Rane 
(2017) highlighted the importance of such readily 
accessible regulatory expertise for MD development. 
Ventilators also have to be manufactured accord-
ing to specific MD QMS (e.g. ISO13485). Hence, 
non- MD manufacturers needed to be audited and 
certified before they could produce any MDs. In the 
VCUK, this process was accelerated by creating a list 
with all of the different QMS for defence as well as 
the aerospace and automotive sectors, which facili-
tated the identification of gaps between the QMS for 
the MHRA and the Notified Bodies.
By engaging in the UKVC, many of the involved 
SMEs reported that working with the larger manufac-
turing firms had allowed them to demonstrate their 
capabilities, and this had resulted in the develop-
ment of new collaborative opportunities. In addition, 
the experience of working with organisations from 
different sectors led some organisations to report a 
desire to explore further cross- sector opportunities, 
something that they felt they were unlikely to have 
done prior to involvement in the UKVC.
The UKVC therefore illustrates three key issues 
relating to technical competency in collaborations. 
Firstly, having easily accessible and appropriately 
sophisticated domain- specific MDD expertise within 
the consortium was essential to ensuring focus on the 
key issues. Secondly, while it would have been ideal 
if all partners had expertise in MDD, this was not pos-
sible as the UK MD sector is not sufficiently large. 
However, drawing in partners from sectors with cog-
nate characteristics (e.g. aerospace and motorsport, 
where adherence to safety standards and regulations 
is also fundamental) ensured that cultural and oper-
ational barriers between MD and non- MD partners 
were minimised. Finally, the UKVC allowed smaller 
firms to demonstrate their potential as partners for 
future collaborative projects with firms with which 
they might otherwise have struggled to engage.
4.3.  Knowledge management
UK- wide lock- down restrictions meant that remote 
working had to be adopted widely for the UKVC. 
Despite face- to- face dialogue being “[…] at the heart 
of a process of building trust, mutual respect, shared 
understanding, and commitment to the process” 
Figure 6. RMVS specification versions (Source: MHRA website).
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(Ansell and Gash, 2007, p. 558), the consortia had 
to ensure that all those who could do so were able 
to work from home. Digital communication software 
(e.g. Microsoft Teams) was rapidly rolled- out and 
structured to enable the separation between private 
and public channels so that IP- sensitive information 
could be readily shared with selected team members.
An important aspect for most projects was the 
ability to capture and transfer MD- specific tacit and 
explicit knowledge to people from non- MD indus-
tries. This included knowledge about compliance- 
relevant material handling and documentation as 
well as the training of manufacturing and assembly 
staff. The shift from low volume to very high volume 
production at a high skill level caused the need to 
capture, as one interviewee put it, “tacit knowledge 
[…] that has never been captured because it didn’t 
need to be”. The need to transfer tacit knowledge 
is well- explored in collaborative NPD (Ramesh and 
Tiwana, 1999; Emden et al., 2006) but to facilitate 
the transfer and conversion of knowledge, Noran 
(2014, p. 1034) concludes that “the only current 
solution appears to be the regular immersion of the 
participant organisations in each other’s cultures”. In 
the VCUK, digital technologies such as virtual/aug-
mented reality (VR/AR) enabled, for example, the 
Penlon team to remotely assist the Ford people work-
ing on the assembly line. Other digital tools included 
electronic documentation as well as digital model-
ling and simulation of production and assembly lines 
which enabled rapid digital validation for the imple-
mentation of measures such as social distancing.
Whereas some research argues that knowledge- 
related barriers such as the recipient’s lack of absorp-
tive capacity play a major role in inhibiting knowledge 
sharing (Szulanski, 1996), Siemsen et al. (2008) 
underline the pivotal role of motivation in inter- 
employee knowledge sharing. Using a constraining- 
factor logic of the motivation- opportunity- ability 
(MOA) model, their empirical research shows that 
very high motivation can enable employees to over-
come potentially constraining factors such as time 
pressure or virtual communication. In this case, the 
strong common goal stimulated employees’ motiva-
tion with neither constrained opportunity (e.g. time 
pressure) nor the lack of ability (thanks to using the 
“strongest- athletes for the task” as explained in chap-
ter 4.4) limiting effective knowledge sharing.
Another major challenge noted during the anal-
ysis was the presence of supply chain bottlenecks 
around ventilator components since manufacturers 
around the world were all procuring similar parts. 
Established MD suppliers experienced a huge rise 
in demand, with some of it being real some of it 
being ‘phantom’: e.g. one MD component supplier 
reported almost thirty different and uncoordinated 
avenues of inquiry which turned out to allrelate to 
one single project. Moreover, some suppliers noted 
challenges arising from a lack of supplier involve-
ment in some projects causing multiple re- works 
since suppliers were unable to understand the tech-
nical requirements of some components. Exchanging 
knowledge and closely cooperating with the supply 
chain can overcome these bottlenecks, as previously 
identified by García- Villarreal et al. (2019).
4.4.  Project management
The new design projects faced a design and devel-
opment task that usually takes multiple years but 
was compressed into a timeline of six weeks, while 
scale- up projects had to produce an estimated ten 
years’ worth of normal ventilator production within 
the space of three months.
Interviewees noted three factors which contributed 
to project acceleration: high and aligned priorities, 
strong leadership skills, and highly capable project 
members. In normal business, as described by one 
interviewee, it would be: “[…] very rare […] that this 
kind of group would be given the same priority, […] 
not focusing on anything else”, which is reflected in 
the literature on NPD crisis management (Muenzberg 
et al., 2016). The benefits of senior management 
involvement and strong leadership skills, including 
political and stakeholder management, have been 
identified in many research areas, especially cross- 
functional teamwork (Holland et al., 2000), MDD 
processes (Ocampo and Kaminski, 2019), and NPD 
crisis management literature (Akgün et al., 2007).
Lastly, the ability to access what was described 
by one interviewee as: “the strongest athlete for the 
task” was highlighted as essential for the success of 
the UKVC projects. The benefits of the right “skills 
of [the] engineers [...] involved” (Pietzsch et al., 2009, 
p. 021004- 1) have been noted in the MDD literature 
which also outlines how difficult this is to emulate 
for more routine projects. With the tight timescales, 
decision- making needed to be fast- tracked which was 
achieved by empowering team members with an appro-
priate level of autonomy needed for rapid decision- 
making. Hence, decisions were not made top- down but 
placed at what one interviewee called “[…] the point of 
greatest knowledge”, reflecting what is observed in the 
literature (Ocampo and Kaminski, 2019).
5.  Conclusions
In the history of mechanical ventilation, major pub-
lic health emergencies such as the polio epidemic 
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led to major advancements in mechanical ventilation 
(Slutsky, 2015). This paper has sought to answer the 
question: What lessons can be synthesised from the 
rapid setup and management of the medical device 
design and manufacturing consortia to support future 
rapid design and scale- up projects? This question 
was addressed through the collection and analysis 
of primary data from 32 semi- structured interviews 
with stakeholders and 42 sources of secondary data. 
As summarised in Table  4, thematic coding of the 
transcripts yielded six major lessons learned.
5.1.  Managerial implications
The findings in Table 4 complement known factors 
identified in prior research but illustrate lessons for 
managers of NPD and scale- up projects that can be 
drawn from their application in an extremely chal-
lenging ‘high pressure’ context. For example, this 
research showed the positive impact of having a 
common, easily communicable goal which can help 
override disagreements that may arise from differ-
ing company- specific interests of partners in any 
NPD collaboration. In addition, this research high-
lighted the way in which new staffing models for 
urgent and high- priority NPD projects could draw 
upon the selective use of the “strongest athlete for 
the task”. Analysis of the consortia also showed how 
the use of devolved leadership models, which allow 
decision- making “at the point of greatest knowl-
edge” rather than more traditional hierarchies, can 
avoid delays and support the acceleration of NPD 
project outcomes.
5.2.  Limitations
This research is exploratory in nature, relied pre-
dominantly on qualitative data from interviews and 
selected secondary sources, and was focused on a 
unique context. As such, the generalisability of find-
ings is limited. The research was also undertaken in 
the midst of the COVID- 19 lockdown in the UK, and 
sought to capture data from a live and high- pressure 
project. As a result, interviews were limited in time 
and covered topics in varying depth and breadth. 
Furthermore, stakeholders might have felt obliged to 
adhere to official corporate views in some of their 
responses. Primary and secondary data was collected 
in the period of May to August 2020. Given the high 
profile of this project, and level and speed of public 
expenditure, on- going public reviews will no doubt 
reveal further insights that will require additional 
analysis. The cross- sectional nature of the study also 
limits the ability to infer causality of the observed 
phenomena.
5.3.  Further research
The exploratory and qualitative nature of the study 
means that it is not possible to draw widely general-
isable nor definitive conclusions from the analysis. 
To validate the findings of this study, a quantita-
tive study with a larger sample size could provide 
Table 4. Summary of key findings
CSFs identified in literature review Findings from the study
Managers should give clear targets (Muenzberg et al., 2016) Strong, appealing common goal reduced competitive 
tension, facilitated trust and ensured access to the best 
resources
Common organisational objective (Holland et al., 2000)
High level of perceived crisis can result in better NPD 
performance (Samra et al., 2019)
Different organisational cultures can act as drivers of crises 
in collaborative NPD (Lynch et al., 2014)
The involvement & collaboration of companies of dif-
ferent sizes and varying expertise can have mutually 
beneficial long- term effects
Face- to- face communication is essential for trust, mutual 
respect and commitment (Ansell and Gash, 2007)
Crucial role of employee motivation, supported through 
digital tools and highly capable employees, to ensure 
effective knowledge sharingKnowledge sharing behaviour among employees can be 
restricted by their motivation, opportunity or ability 
(Siemsen et al., 2008)
Cooperation and knowledge exchange between OEM and 
supply chain (García- Villarreal et al., 2019)
Early and open involvement of suppliers needed to 
avoid bottlenecks
Experts & their expertise needed (Pietzsch et al., 2009; 
Muenzberg et al., 2016; Kirkire and Rane, 2017)
Being able to choose the experienced specialists facili-
tates productivity – ‘pick the strongest athlete for the 
task’
Management attention and support needed (Akgün et al., 
2007; Muenzberg et al., 2016)
Maximum productivity achieved through empowerment 
of team members – ‘put the decision at the point of 
greatest knowledge’Strong leadership skills required for successful MDD 
(Ocampo and Kaminski, 2019)
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more generalisability. Given the pandemic nature 
of COVID- 19 and the numerous consortia formed 
globally to address similar challenges to those faced 
in the UK, there are multiple opportunities for such 
research to be undertaken.
Delving more deeply into the tentative long- term 
outcomes could also serve as a source of further 
research. The experiences in the UKVC may lead to 
similar cross- sector collaborations tackling national 
and international policy in relation to ‘grand chal-
lenges’ such as climate change. Moreover, compa-
nies involved in the UKVC may be more open to 
leverage synergies from commercial cross- sector 
collaborations. A longitudinal study, following col-
laborative NPD or MDD projects in companies that 
were involved in the UKVC, could be another avenue 
of exploration.
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